225 related articles for article (PubMed ID: 18087146)
41. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Büyükçelik A; Yalçin B; Utkan G; Doruk H
Cancer; 2004 Sep; 101(5):1100-1; author reply 1101. PubMed ID: 15329922
[No Abstract] [Full Text] [Related]
42. Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Kim TK; Xu ML; Podoltsev NA; Prebet T; Barbarotta L; Amin K; Kasberg S; Roche K; Stahl M; Gore SD; Zeidan AM
Ann Hematol; 2016 Oct; 95(11):1895-8. PubMed ID: 27468851
[No Abstract] [Full Text] [Related]
43. Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.
La Spina M; Catania R; Lo Nigro L; De Grandi C; Palmucci S; Di Cataldo A
Pediatr Hematol Oncol; 2010 May; 27(4):320-3. PubMed ID: 20426524
[No Abstract] [Full Text] [Related]
44. Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
Deenik W; Beverloo HB; van der Poel-van de Luytgaarde SC; Wattel MM; van Esser JW; Valk PJ; Cornelissen JJ
Leukemia; 2009 Mar; 23(3):627-9. PubMed ID: 18987655
[No Abstract] [Full Text] [Related]
45. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.
Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G
Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268
[TBL] [Abstract][Full Text] [Related]
46. Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct endothelial injury.
Mahadeo KM; Dhall G; Panigrahy A; Lastra C; Ettinger LJ
Pediatr Hematol Oncol; 2010 Feb; 27(1):46-52. PubMed ID: 20121554
[TBL] [Abstract][Full Text] [Related]
47. Variant of classical high grade PTLD: post-transplant EBV-negative T cell lymphoblastic leukaemia after solid organ transplantation.
Teiken K; Kreipe H; Maecker-Kolhoff B; Hussein K
Ann Hematol; 2017 Aug; 96(8):1403-1405. PubMed ID: 28616657
[No Abstract] [Full Text] [Related]
48. Roles of protein C, protein S, and antithrombin III in acute leukemia.
Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
[TBL] [Abstract][Full Text] [Related]
49. [Granular CALLA-positive acute lymphoblastic leukemia].
De Salvo Cardullo L; Weir Madina J; Gómez Sánchez O; Plumacher Z; Salas D
Invest Clin; 1990; 31(3):153-61. PubMed ID: 2101643
[TBL] [Abstract][Full Text] [Related]
50. Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia.
Goldschmidt N; Gural A; Kornberg A; Spectre G; Shopen A; Paltiel O
Am J Hematol; 2004 Aug; 76(4):364-7. PubMed ID: 15282670
[TBL] [Abstract][Full Text] [Related]
51. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
[TBL] [Abstract][Full Text] [Related]
52. Half-and-half nails in a pediatric patient after chemotherapy.
Afsar FS; Ozek G; Vergin C
Cutan Ocul Toxicol; 2015; 34(4):350-1. PubMed ID: 25597374
[TBL] [Abstract][Full Text] [Related]
53. Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
Rausch CR; Jabbour EJ; Kantarjian HM; Kadia TM
Cancer; 2020 Mar; 126(6):1152-1160. PubMed ID: 31794095
[No Abstract] [Full Text] [Related]
54. Results of a multicentre study of the treatment of acute lymphoblastic leukaemia in adolescents and adults (1978-1981).
Willemze R; Haanen C; Dekker A; Sizoo W; Abels J; Tricot G; Kerkhofs H; von dem Borne A; Kurstjens R; Roozendaal KJ; Goudsmit R
Neth J Med; 1982; 25(9):303-7. PubMed ID: 6757770
[No Abstract] [Full Text] [Related]
55. [Intensive chemotherapy of acute lymphoblastic leukemia in childhood: evaluation of our experience].
Tontoli N; Correra A; Saviano P; Vetrella A; De Masi RV; Florino G; Lagonigro F
Pediatria (Napoli); 1981 Dec; 89(4):805-13. PubMed ID: 6955759
[No Abstract] [Full Text] [Related]
56. Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL.
Turner SR; Pinsk M
J Pediatr Hematol Oncol; 2008 Jan; 30(1):58-60. PubMed ID: 18176182
[TBL] [Abstract][Full Text] [Related]
57. A unique breast involvement detected by MRI-DWIBS in T cell acute lymphoblastic leukemia.
Katagiri S; Azuma K; Akahane D; Saito K; Ohyashiki K
Breast J; 2019 Nov; 25(6):1276-1277. PubMed ID: 31301079
[No Abstract] [Full Text] [Related]
58. T-cell acute lymphoblastic leukemia with t(1;18)(p36;q22).
Kowal-Vern A; Melnyk A
Cancer Genet Cytogenet; 1990 Nov; 50(1):31-3. PubMed ID: 2253188
[TBL] [Abstract][Full Text] [Related]
59. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
[No Abstract] [Full Text] [Related]
60. Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
Barfield RC; Hale GA; Burnette K; Behm FG; Knapp K; Eldridge P; Handgretinger R
Pediatr Blood Cancer; 2007 Mar; 48(3):349-53. PubMed ID: 16302216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
